GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma A/S (NAS:ASND) » Definitions » E10

Ascendis Pharma A/S (Ascendis Pharma A/S) E10 : $-6.49 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Ascendis Pharma A/S E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Ascendis Pharma A/S's adjusted earnings per share data for the three months ended in Mar. 2024 was $-2.500. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-6.49 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-06-07), Ascendis Pharma A/S's current stock price is $138.28. Ascendis Pharma A/S's E10 for the quarter that ended in Mar. 2024 was $-6.49. Ascendis Pharma A/S's Shiller PE Ratio of today is .


Ascendis Pharma A/S E10 Historical Data

The historical data trend for Ascendis Pharma A/S's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Pharma A/S E10 Chart

Ascendis Pharma A/S Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -6.15

Ascendis Pharma A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.73 -5.78 -5.99 -6.15 -6.49

Competitive Comparison of Ascendis Pharma A/S's E10

For the Biotechnology subindustry, Ascendis Pharma A/S's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ascendis Pharma A/S's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascendis Pharma A/S's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Ascendis Pharma A/S's Shiller PE Ratio falls into.



Ascendis Pharma A/S E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ascendis Pharma A/S's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-2.5/118.4000*118.4000
=-2.500

Current CPI (Mar. 2024) = 118.4000.

Ascendis Pharma A/S Quarterly Data

per share eps CPI Adj_EPS
201406 -0.269 99.700 -0.319
201409 -0.151 99.700 -0.179
201412 -0.367 99.400 -0.437
201503 0.065 100.200 0.077
201506 -0.707 100.300 -0.835
201509 -0.337 100.200 -0.398
201512 -0.534 99.800 -0.634
201603 -0.913 100.200 -1.079
201606 -0.596 100.600 -0.701
201609 -0.808 100.200 -0.955
201612 -0.538 100.300 -0.635
201703 -0.834 101.200 -0.976
201706 -1.056 101.200 -1.235
201709 -1.240 101.800 -1.442
201712 -1.089 101.300 -1.273
201803 -1.319 101.700 -1.536
201806 -0.643 102.300 -0.744
201809 -0.945 102.400 -1.093
201812 -0.865 102.100 -1.003
201903 -1.401 102.900 -1.612
201906 -1.412 102.900 -1.625
201909 -0.584 102.900 -0.672
201912 -1.889 102.900 -2.174
202003 -1.459 103.300 -1.672
202006 -2.218 103.200 -2.545
202009 -2.721 103.500 -3.113
202012 -3.212 103.400 -3.678
202103 -1.393 104.300 -1.581
202106 -3.012 105.000 -3.396
202109 -1.729 105.800 -1.935
202112 -2.113 106.600 -2.347
202203 -2.434 109.900 -2.622
202206 -1.543 113.600 -1.608
202209 -3.000 116.400 -3.052
202212 -3.919 115.900 -4.004
202303 -2.120 117.300 -2.140
202306 -2.340 116.400 -2.380
202309 -3.074 117.400 -3.100
202312 -1.679 116.700 -1.703
202403 -2.500 118.400 -2.500

Add all the adjusted EPS together and divide 10 will get our e10.


Ascendis Pharma A/S  (NAS:ASND) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Ascendis Pharma A/S E10 Related Terms

Thank you for viewing the detailed overview of Ascendis Pharma A/S's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Ascendis Pharma A/S (Ascendis Pharma A/S) Business Description

Traded in Other Exchanges
Address
Tuborg Boulevard 12, Hellerup, DNK, DK-2900
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.